22.418 articles found

The performance of motor tasks in Parkinsonian patients treated with levodopa and surgery : does the patient's perception of their ability match their actual ability?

Joint C.

· 2007-01-01

Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Montgomery EB.

Neurology · 2007-01-01

DOI: 10.1212/01.wnl.0000215428.46057.3dPMID: 16585044

Drug discarding: a problematic therapeutic event in Parkinson's disease.

Miwa H, Hiwatani Y, Kondo T.

Mov Disord · 2007-01-01

DOI: 10.1002/mds.21190PMID: 17083092

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.

Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H.

Mov Disord · 2007-01-01

DOI: 10.1002/mds.21226PMID: 17094088

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J.

Mov Disord · 2007-01-01

DOI: 10.1002/mds.21222PMID: 17133512

Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease.

Gasmi M, Herzog CD, Brandon EP, Cunningham JJ, Ramirez GA, Ketchum ET, Bartus RT.

Mol Ther · 2007-01-01

DOI: 10.1038/sj.mt.6300010PMID: 17164776

Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease.

Tamir R, Dickstein R, Huberman M.

Neurorehabil Neural Repair · 2007-01-01

DOI: 10.1177/1545968306292608PMID: 17172556

Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Aarsland D, Emre M, Lees A, Poewe W, Ballard C.

Neurology · 2007-01-01

DOI: 10.1212/01.wnl.0000252956.34585.a6PMID: 17200503

[Medical treatment of Parkinson's disease].

Waldvogel D.

Ther Umsch · 2007-01-01

DOI: 10.1024/0040-5930.64.1.15PMID: 17221820

The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.

Hodaie M, Neimat JS, Lozano AM.

Neurosurgery · 2007-01-01

DOI: 10.1227/01.neu.0000249209.11967.cbPMID: 17228250

Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA.

Eur J Neurosci · 2007-01-01

DOI: 10.1111/j.1460-9568.2006.05265.xPMID: 17241287

Clozapine for the treatment of neurogenic bladder.

Kumar A, Chadda RK, Kumar N, Balan S, Prakash Srinivasan S.

Neurourol Urodyn · 2007-01-01

DOI: 10.1002/nau.20399PMID: 17245773